Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Education, Pharmacy | 5 | 2024 | 115 | 2.540 |
Why?
|
| Pharmacists | 9 | 2019 | 72 | 1.980 |
Why?
|
| Community Pharmacy Services | 5 | 2017 | 22 | 1.800 |
Why?
|
| Pharmacy | 4 | 2022 | 35 | 1.690 |
Why?
|
| Pharmaceutical Services | 5 | 2019 | 41 | 1.400 |
Why?
|
| Medication Therapy Management | 5 | 2015 | 18 | 1.310 |
Why?
|
| Students, Pharmacy | 2 | 2024 | 83 | 1.080 |
Why?
|
| Diabetes Mellitus | 4 | 2024 | 215 | 1.060 |
Why?
|
| Problem-Based Learning | 1 | 2024 | 61 | 0.850 |
Why?
|
| Public Health | 1 | 2024 | 93 | 0.830 |
Why?
|
| Hypoglycemic Agents | 2 | 2017 | 107 | 0.800 |
Why?
|
| Program Evaluation | 3 | 2015 | 167 | 0.670 |
Why?
|
| Checklist | 1 | 2019 | 22 | 0.630 |
Why?
|
| Antihypertensive Agents | 2 | 2017 | 56 | 0.610 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2015 | 14 | 0.590 |
Why?
|
| Hepatitis B Vaccines | 1 | 2017 | 3 | 0.540 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 75 | 0.520 |
Why?
|
| Medication Adherence | 1 | 2017 | 48 | 0.520 |
Why?
|
| Surveys and Questionnaires | 5 | 2024 | 971 | 0.500 |
Why?
|
| Patient-Centered Care | 1 | 2015 | 31 | 0.480 |
Why?
|
| Curriculum | 3 | 2024 | 291 | 0.480 |
Why?
|
| Vaccination | 1 | 2017 | 186 | 0.480 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 100 | 0.450 |
Why?
|
| Humans | 20 | 2024 | 28097 | 0.430 |
Why?
|
| Professional Role | 5 | 2015 | 46 | 0.410 |
Why?
|
| Managed Care Programs | 1 | 2012 | 16 | 0.380 |
Why?
|
| Community Health Services | 1 | 2012 | 32 | 0.370 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2024 | 297 | 0.360 |
Why?
|
| Disease Management | 1 | 2012 | 88 | 0.360 |
Why?
|
| Male | 10 | 2024 | 13491 | 0.350 |
Why?
|
| Female | 10 | 2024 | 15156 | 0.330 |
Why?
|
| Models, Organizational | 1 | 2008 | 18 | 0.300 |
Why?
|
| Patient Compliance | 1 | 2009 | 75 | 0.300 |
Why?
|
| Quality of Health Care | 1 | 2009 | 80 | 0.300 |
Why?
|
| Adult | 8 | 2024 | 7740 | 0.300 |
Why?
|
| Research | 1 | 2008 | 92 | 0.290 |
Why?
|
| Educational Measurement | 2 | 2024 | 127 | 0.280 |
Why?
|
| Middle Aged | 7 | 2024 | 7138 | 0.260 |
Why?
|
| Communication | 1 | 2008 | 178 | 0.250 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 2021 | 0.250 |
Why?
|
| Aged | 7 | 2024 | 5400 | 0.250 |
Why?
|
| Social Responsibility | 1 | 2004 | 11 | 0.230 |
Why?
|
| Drug Therapy | 1 | 2004 | 15 | 0.230 |
Why?
|
| Hearing Loss | 1 | 2024 | 39 | 0.210 |
Why?
|
| Health Policy | 1 | 2024 | 61 | 0.210 |
Why?
|
| Cooperative Behavior | 2 | 2015 | 77 | 0.210 |
Why?
|
| Treatment Outcome | 2 | 2009 | 2379 | 0.200 |
Why?
|
| Psychometrics | 1 | 2022 | 121 | 0.190 |
Why?
|
| Health Status | 1 | 2002 | 148 | 0.180 |
Why?
|
| Pandemics | 1 | 2022 | 186 | 0.170 |
Why?
|
| Depression | 1 | 2002 | 216 | 0.170 |
Why?
|
| Health Literacy | 1 | 2020 | 33 | 0.170 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 769 | 0.170 |
Why?
|
| Patient Care | 1 | 2019 | 13 | 0.160 |
Why?
|
| Research Report | 1 | 2019 | 23 | 0.160 |
Why?
|
| Advisory Committees | 1 | 2019 | 32 | 0.160 |
Why?
|
| Health Care Surveys | 2 | 2012 | 67 | 0.150 |
Why?
|
| Young Adult | 2 | 2024 | 2733 | 0.150 |
Why?
|
| Diabetes Complications | 2 | 2024 | 66 | 0.150 |
Why?
|
| Cross-Sectional Studies | 5 | 2024 | 961 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 243 | 0.140 |
Why?
|
| Hypertension | 2 | 2012 | 308 | 0.140 |
Why?
|
| Appointments and Schedules | 1 | 2017 | 8 | 0.140 |
Why?
|
| Midwestern United States | 1 | 2017 | 38 | 0.140 |
Why?
|
| Hepatitis B | 1 | 2017 | 13 | 0.130 |
Why?
|
| Ambulatory Care Facilities | 1 | 2017 | 54 | 0.130 |
Why?
|
| Internship and Residency | 2 | 2017 | 239 | 0.130 |
Why?
|
| Interviews as Topic | 2 | 2008 | 157 | 0.120 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2015 | 10 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 97 | 0.120 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 19 | 0.120 |
Why?
|
| Health Care Costs | 1 | 2015 | 50 | 0.120 |
Why?
|
| Aging | 1 | 2002 | 968 | 0.120 |
Why?
|
| Medication Errors | 1 | 2015 | 26 | 0.120 |
Why?
|
| Family Practice | 1 | 2015 | 45 | 0.120 |
Why?
|
| Medical Waste Disposal | 1 | 2014 | 1 | 0.110 |
Why?
|
| Patient Participation | 1 | 2014 | 56 | 0.110 |
Why?
|
| Costs and Cost Analysis | 1 | 2012 | 40 | 0.090 |
Why?
|
| Cholesterol, LDL | 1 | 2012 | 64 | 0.090 |
Why?
|
| Glycated Hemoglobin A | 1 | 2012 | 64 | 0.090 |
Why?
|
| Blood Pressure | 1 | 2012 | 354 | 0.090 |
Why?
|
| United States | 4 | 2020 | 2146 | 0.080 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2008 | 9 | 0.070 |
Why?
|
| Program Development | 1 | 2008 | 78 | 0.070 |
Why?
|
| Competency-Based Education | 1 | 2008 | 17 | 0.070 |
Why?
|
| Professional-Patient Relations | 1 | 2008 | 28 | 0.070 |
Why?
|
| Florida | 1 | 2004 | 54 | 0.060 |
Why?
|
| Pharmacies | 1 | 2004 | 19 | 0.060 |
Why?
|
| Ambulatory Care | 1 | 2004 | 60 | 0.060 |
Why?
|
| Drug Prescriptions | 1 | 2004 | 46 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2024 | 97 | 0.050 |
Why?
|
| Health Personnel | 1 | 2024 | 95 | 0.050 |
Why?
|
| Mass Screening | 1 | 2024 | 152 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2002 | 68 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 145 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2002 | 98 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2002 | 236 | 0.050 |
Why?
|
| Residence Characteristics | 1 | 2002 | 104 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2002 | 302 | 0.050 |
Why?
|
| Logistic Models | 1 | 2002 | 407 | 0.050 |
Why?
|
| Sex Factors | 1 | 2002 | 466 | 0.040 |
Why?
|
| Oklahoma | 1 | 2024 | 1007 | 0.040 |
Why?
|
| Canada | 1 | 2020 | 60 | 0.040 |
Why?
|
| Cultural Competency | 1 | 2020 | 18 | 0.040 |
Why?
|
| Data Collection | 2 | 2008 | 105 | 0.040 |
Why?
|
| Risk Factors | 1 | 2002 | 2081 | 0.030 |
Why?
|
| Prescription Drugs | 1 | 2014 | 15 | 0.030 |
Why?
|
| Investments | 1 | 2008 | 1 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2008 | 112 | 0.020 |
Why?
|